C. Daniel Mullins, PhD


Professor of Practice, Sciences, and Health Outcomes Research

Executive Director, PATIENTS Program

School Affiliation

School of Pharmacy


  • Pharmacoeconomics
  • Comparative Effectiveness Research
  • Health Disparities


Dr. Mullins’ research and teaching focus on community-engaged, patient-centered comparative effectiveness research to advance health equity. He has received funding as principal investigator from the Agency for Healthcare Research and Quality (AHRQ), the Food and Drug Administration (through its CERSI initiative), the National Institute on Aging (NIA), the National Institute on Minority Health and Health Disparities, the Patient-Centered Outcomes Research Institute (PCORI), various pharmaceutical manufacturers, patient advocacy organizations, and the insurance industry. In addition to his faculty appointment, Dr. Mullins is executive director of The PATIENTS Program at the School of Pharmacy and director of the Community & Collaboration Core for the UMB Institute for Clinical and Translational Research, as well as editor-in-chief for the journal Value in Health.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: Global Health   Ensuring Access and Equity in Health Care   Caring for the Human Condition   Community Engagement   Research and Innovation   Equity, Diversity, and Inclusion  

This information was last updated January 13, 2023.